McKesson Corporation is one of the largest global healthcare companies, and its net worth in 2020 reflected decades of scale, supply chain dominance, and sector influence. The company’s operations span pharmaceuticals, medical supplies, and digital health platforms, shaping how providers access and pay for goods.
By 2020, McKesson navigated pandemic-driven demand surges and margin pressures while maintaining a massive footprint across North America and beyond. Analysts assessed its net worth through revenue, adjusted earnings, and balance sheet strength within a volatile healthcare policy environment.
| Metric | 2019 | 2020 | Notes |
|---|---|---|---|
| Annual Revenue (USD billion) | 133.7 | 130.6 | Slight decline due to pricing and volume mix |
| Reported Net Income (USD billion) | 2.4 | 1.9 | Pension adjustments and legal costs reduced profit |
| Operating Cash Flow (USD billion) | 5.4 | 5.1 | Strong cash generation despite COVID-19 costs |
| Estimated Net Worth (Enterprise Value, USD billion) | 180 | 170 | Market-based valuation at year-end 2020 |
| Shareholder Equity (USD billion) | 54.2 | 50.8 | Reflects retained earnings and capital structure changes |